Open Access

CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells

  • Authors:
    • Long‑Qiao Cao
    • Ya‑Nan Wang
    • Ming Liang
    • Mei‑Zhou Pan
  • View Affiliations

  • Published online on: April 30, 2019     https://doi.org/10.3892/mmr.2019.10212
  • Pages: 5097-5104
  • Copyright: © Cao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Numerous studies have demonstrated the association between senescence and cancer. However, the molecular mechanism regulating senescence in ovarian cancer remains unknown. In the present study, the protein expression level of calbindin 1 (CALB1) in ovarian cancer was examined using western blot and immunohistochemistry. The function of CALB1 in ovarian cancer cells was examined using MTT assay, anchorage‑independent growth assay and senescence assay. The molecular mechanisms underlying CALB1 function were investigated using immunoprecipitation and pull‑down assays. In the present study, the expression of CALB1 was found to be increased in ovarian cancer. Overexpression of CALB1 promoted the proliferation and colony formation of ovarian cancer cells and inhibited senescence by modulating the expression levels of p21 and p27. Knockdown of CALB1 inhibited the proliferation and colony formation of ovarian cancer cells. Mechanistically, co‑immunoprecipitation assays revealed that CALB1 interacts with MDM2 proto‑oncogene (MDM2) and promoted the interaction between p53 and MDM2. Collectively, the present study suggested that CALB1 may act as an oncogene in ovarian cancer by inhibiting the p53 pathway.

References

1 

Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A and Siegel RL: Ovarian cancer statistics, 2018. CA Cancer J Clin. 68:284–296. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Mori R, Futamura M, Morimitsu K, Saigo C, Miyazaki T and Yoshida K: The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: A case report. World J Surg Oncol. 15:1172017. View Article : Google Scholar : PubMed/NCBI

4 

Nakayama N, Nakayama K, Yeasmin S, Ishibashi M, Katagiri A, Iida K, Fukumoto M and Miyazaki K: KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer. Br J Cancer. 99:2020–2028. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Bennett MR and Clarke MC: Basic research: Killing the old: Cell senescence in atherosclerosis. Nat Rev Cardiol. 14:8–9. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Burgess DJ: Senescence: Double or quit? Nat Rev Cancer. 11:3892011. View Article : Google Scholar : PubMed/NCBI

7 

Mathon NF and Lloyd AC: Cell senescence and cancer. Nat Rev Cancer. 1:203–213. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Burgess DJ: Senescence: Tumorigenesis under surveillance. Nat Rev Cancer. 12:62011. View Article : Google Scholar : PubMed/NCBI

9 

Visser JA, Schipper I, Laven JS and Themmen AP: Anti-Mullerian hormone: An ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 8:331–341. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Nardella C, Clohessy JG, Alimonti A and Pandolfi PP: Pro-senescence therapy for cancer treatment. Nat Rev Cancer. 11:503–511. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Campisi J and d'Adda di Fagagna F: Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol. 8:729–740. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Killock D: Chemotherapy: Life gained, years lost? Nat Rev Clin Oncol. 11:3032014. View Article : Google Scholar : PubMed/NCBI

13 

Collado M and Serrano M: Senescence in tumours: Evidence from mice and humans. Nat Rev Cancer. 10:51–57. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Li J, Mao Q, He J, She H, Zhang Z and Yin C: Human umbilical cord mesenchymal stem cells improve the reserve function of perimenopausal ovary via a paracrine mechanism. Stem Cell Res Ther. 8:552017. View Article : Google Scholar : PubMed/NCBI

15 

Mikuła-Pietrasik J, Uruski P, Pakuła M, Maksin K, Szubert S, Woźniak A, Naumowicz E, Szpurek D, Tykarski A and Książek K: Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells. Free Radic Biol Med. 110:270–279. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Jung EM, Choi KC and Jeung EB: Expression of calbindin-D28k is inversely correlated with proapototic gene expression in hydrogen peroxide-induced cell death in endometrial cancer cells. Int J Oncol. 38:1059–1066. 2011.PubMed/NCBI

17 

Goffigan-Holmes J, Sanabria D, Diaz J, Flock D and Chavez-Valdez R: Calbindin-1 expression in the hippocampus following neonatal hypoxia-ischemia and therapeutic hypothermia and deficits in spatial memory. Dev Neurosci. March 12–2019.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

18 

Parkash J, Chaudhry MA and Rhoten WB: Calbindin-D28k and calcium sensing receptor cooperate in MCF-7 human breast cancer cells. Int J Oncol. 24:1111–1119. 2004.PubMed/NCBI

19 

Massouh M, Wallman MJ, Pourcher E and Parent A: The fate of the large striatal interneurons expressing calretinin in Huntington's disease. Neurosci Res. 62:216–224. 2008. View Article : Google Scholar : PubMed/NCBI

20 

Cai Z, Qian ZY, Jiang H, Ma N, Li Z, Liu LY, Ren XX, Shang YR, Wang JJ, Li JJ, et al: hPCL3s promotes hepatocellular carcinoma metastasis by activating β-catenin signaling. Cancer Res. 78:2536–2549. 2018. View Article : Google Scholar : PubMed/NCBI

21 

Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long LY, Li G, Ji XD, Shi S, Guan DX, et al: RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex. Gastroenterology. 142:812–823.e15. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI

23 

Levine AJ: The p53 tumor suppressor gene and gene product. Princess Takamatsu Symp. 20:221–230. 1989.PubMed/NCBI

24 

Ohtani N, Mann DJ and Hara E: Cellular senescence: Its role in tumor suppression and aging. Cancer Sci. 100:792–797. 2009. View Article : Google Scholar : PubMed/NCBI

25 

Jin C, Lin T and Shan L: Downregulation of Calbindin 1 by miR-454-3p suppresses cell proliferation in nonsmall cell lung cancer in vitro. Cancer Biother Radiopharm. 34:119–127. 2019. View Article : Google Scholar : PubMed/NCBI

26 

Yang F, von Knethen A and Brune B: Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1). J Leukoc Biol. 68:916–922. 2000.PubMed/NCBI

27 

Labidi-Galy SI, Olivier T, Rodrigues M, Ferraioli D, Derbel O, Bodmer A, Petignat P, Rak B, Chopin N, Tredan O, et al: Location of mutation in BRCA2 gene and survival in patients with ovarian cancer. Clin Cancer Res. 24:326–333. 2018. View Article : Google Scholar : PubMed/NCBI

28 

Schuyer M, van Staveren IL, Klijn JG, vd Burg ME, Stoter G, Henzen-Logmans SC, Foekens JA and Berns EM: Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours. Br J Cancer. 74:1069–1073. 1996. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 19 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Cao, L., Wang, Y., Liang, M., & Pan, M. (2019). CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells. Molecular Medicine Reports, 19, 5097-5104. https://doi.org/10.3892/mmr.2019.10212
MLA
Cao, L., Wang, Y., Liang, M., Pan, M."CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells". Molecular Medicine Reports 19.6 (2019): 5097-5104.
Chicago
Cao, L., Wang, Y., Liang, M., Pan, M."CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells". Molecular Medicine Reports 19, no. 6 (2019): 5097-5104. https://doi.org/10.3892/mmr.2019.10212